Alternate protein kinase A activity identifies a unique population of stromal cells in adult bone
- 26 April 2010
- journal article
- research article
- Published by Proceedings of the National Academy of Sciences in Proceedings of the National Academy of Sciences
- Vol. 107 (19), 8683-8688
- https://doi.org/10.1073/pnas.1003680107
Abstract
A population of stromal cells that retains osteogenic capacity in adult bone (adult bone stromal cells or aBSCs) exists and is under intense investigation. Mice heterozygous for a null allele of prkar1a (Prkar1a+/−), the primary receptor for cyclic adenosine monophosphate (cAMP) and regulator of protein kinase A (PKA) activity, developed bone lesions that were derived from cAMP-responsive osteogenic cells and resembled fibrous dysplasia (FD). Prkar1a+/− mice were crossed with mice that were heterozygous for catalytic subunit Cα (Prkaca+/−), the main PKA activity-mediating molecule, to generate a mouse model with double heterozygosity for prkar1a and prkaca (Prkar1a+/−Prkaca+/−). Unexpectedly, Prkar1a+/−Prkaca+/− mice developed a greater number of osseous lesions starting at 3 months of age that varied from the rare chondromas in the long bones and the ubiquitous osteochondrodysplasia of vertebral bodies to the occasional sarcoma in older animals. Cells from these lesions originated from an area proximal to the growth plate, expressed osteogenic cell markers, and showed higher PKA activity that was mostly type II (PKA-II) mediated by an alternate pattern of catalytic subunit expression. Gene expression profiling confirmed a preosteoblastic nature for these cells but also showed a signature that was indicative of mesenchymal-to-epithelial transition and increased Wnt signaling. These studies show that a specific subpopulation of aBSCs can be stimulated in adult bone by alternate PKA and catalytic subunit activity; abnormal proliferation of these cells leads to skeletal lesions that have similarities to human FD and bone tumors.Keywords
This publication has 58 references indexed in Scilit:
- Mouse Prkar1a haploinsufficiency leads to an increase in tumors in the Trp53+/− or Rb1+/− backgrounds and chemically induced skin papillomas by dysregulation of the cell cycle and Wnt signalingHuman Molecular Genetics, 2010
- MicroRNA Signature of Primary Pigmented Nodular Adrenocortical Disease: Clinical Correlations and Regulation of Wnt SignalingCancer Research, 2009
- Constitutively Activated ALK2 and Increased SMAD1/5 Cooperatively Induce Bone Morphogenetic Protein Signaling in Fibrodysplasia Ossificans ProgressivaJournal of Biological Chemistry, 2009
- Skeletal metamorphosis in fibrodysplasia ossificans progressiva (FOP)Journal of Bone and Mineral Metabolism, 2008
- cAMP/PKA pathway activation in human mesenchymal stem cells in vitro results in robust bone formation in vivoProceedings of the National Academy of Sciences, 2008
- Endochondral bone tissue engineering using embryonic stem cellsProceedings of the National Academy of Sciences, 2008
- Targeted Deletion of Prkar1a Reveals a Role for Protein Kinase A in Mesenchymal-to-Epithelial TransitionCancer Research, 2008
- Mutation of Prkar1a Causes Osteoblast Neoplasia Driven by Dysregulation of Protein Kinase AMolecular Endocrinology, 2008
- Developmental regulation of the growth plateNature, 2003
- Gene Expression Omnibus: NCBI gene expression and hybridization array data repositoryNucleic Acids Research, 2002